# Chewing Ticagrelor Versus Prasugrel in ST-elevation Myocardial Infarction - A Platelet Reactivity Study

Study · id `cardio:ct-nct03016611` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03016611](<https://clinicaltrials.gov/study/NCT03016611>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03016611

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

## Technical summary

Registry record NCT03016611. Randomized; no masking; primary purpose treatment. Start 2017-02 (registry gives no type); primary completion 2017-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT03016611, source copy `cardio:ctgov-nct03016611-2017-01-10`, retrieved 2026-10-26)
- Start date: 2017-02 (registry gives no type) (ClinicalTrials.gov record NCT03016611, source copy `cardio:ctgov-nct03016611-2017-01-10`, retrieved 2026-10-26)
- Primary completion: 2017-12 (anticipated) (ClinicalTrials.gov record NCT03016611, source copy `cardio:ctgov-nct03016611-2017-01-10`, retrieved 2026-10-26)
- Completion: Not reported
- Countries: Israel (ClinicalTrials.gov record NCT03016611, source copy `cardio:ctgov-nct03016611-2017-01-10`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03016611-2017-01-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: Chewing Ticagrelor Versus Prasugrel in ST-elevation Myocardial Infarction - A Platelet Reactivity Study
- Condition: Acute Coronary Syndrome
- Condition: STEMI
- Intervention (Drug): Chewing Ticagrelor LD
- Intervention (Drug): Chewing Prasugrel LD
- Lead sponsor: Sheba Medical Center
- Lead sponsor class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry lists this organization as the lead sponsor: Sheba Medical Center (`cardio:org-sheba-medical-center`)

## Provenance

Content hash: aa57c6168694e585f803f1fd7bdc659da38b45417ccfc6f9744dd6490792acf0
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
